Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by PLITheOneon Jun 03, 2021 11:08pm
74 Views
Post# 33327594

RE:Bought rights offer and waiting for 2 more days

RE:Bought rights offer and waiting for 2 more days

"What's the point investing in stocks?"


I think you nailed it on the head there; an entity like Thomvest should not be able to play their unethical game on our publicly traded exchanges! The rules are broken if this behavior is not recognized and future controls implemented to stop these kind of attacks. Sure we are suing for $1 BILLION, but we shouldn't have to. Thousands of investors saw the wrongdoing the moment it happened! Thomvest knew the weakness and loop holes to circumvent the system and screw everyone. No investor would be safe when the same algorithm determines the target. These guys stole this company from long-time investors and have been driving it down for years. If Thomvest's actions are not penalized then there really is no point in investigating in revolutionary high potential companies vulnerable to predators.

StockReady, was I wrong when I told you not to buy rights over two years ago at $15.21? This was after you had already lost large here? I think that you will never recover your losses attempting to hold this falling knife..I feel bad for your situation..

In box me if you like.  



StockReddy wrote: What's the point investing in stocks? if we loose even after FDA approval? I am strongly believing that this will move to above $12 (~15.21CAD) if FDA accepts ryplazim.  

 

<< Previous
Bullboard Posts
Next >>